1. Home
  2. FBP vs ARQT Comparison

FBP vs ARQT Comparison

Compare FBP & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First BanCorp. New

FBP

First BanCorp. New

HOLD

Current Price

$21.25

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$29.31

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBP
ARQT
Founded
1948
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FBP
ARQT
Price
$21.25
$29.31
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$23.67
$24.83
AVG Volume (30 Days)
1.2M
2.4M
Earning Date
01-22-2026
10-28-2025
Dividend Yield
3.40%
N/A
EPS Growth
13.12
N/A
EPS
2.05
N/A
Revenue
$902,789,000.00
$317,929,000.00
Revenue This Year
$12.49
$85.51
Revenue Next Year
$4.57
$30.74
P/E Ratio
$10.33
N/A
Revenue Growth
3.91
129.21
52 Week Low
$16.40
$11.13
52 Week High
$22.61
$31.77

Technical Indicators

Market Signals
Indicator
FBP
ARQT
Relative Strength Index (RSI) 64.68 55.66
Support Level $20.02 $28.30
Resistance Level $21.32 $31.77
Average True Range (ATR) 0.42 1.08
MACD 0.18 -0.44
Stochastic Oscillator 86.10 20.46

Price Performance

Historical Comparison
FBP
ARQT

About FBP First BanCorp. New

First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: